Insights and Analysis
AI-washing – when AI hype becomes a litigation risk
Dr. Mirjam Liebmann, LL.B.
Senior Associate Global Regulatory
Languages
English, German
-
Overview
-
Experience
-
Credentials
-
Insights and events
Mirjam Liebmann advises our national and international clients in the pharmaceutical, medical devices and biotech industry on all kinds of regulatory and commercial matters. The core area of her advice covers pharmaceutical and medical devices law.
Mirjam focuses on the contractual setup of collaborations in the healthcare sector, the advice on compliance aspects when interacting with healthcare professionals and patients / patient organisations, as well as on advertising issues in relation to promoting pharmaceutical products (in the pre- and post-approval stage). She is particularly interested in working closely with her clients on complex issues and developing pragmatic, practical and clear solutions.
She has proven her business-oriented approach during several secondments. She effortlessly understands how to provide appropriate and comprehensible advice and support across all different departments within a company, whether on a national, international, or global level.
Since many years, she is supporting clients in drafting and negotiating clinical trial agreements for Germany, Europe, and worldwide. All kinds of regulatory matters concerning clinical studies are also part of her expertise.
Her extensive compliance experience is highly valued by both clients and colleagues. Accordingly, she is regularly involved in handling matters relating to compliance issues.
Already during her studies, her doctorate studies and her legal traineeship, Mirjam focused on regulatory, advertising and contract law aspects of pharmaceutical and food law.
Before Mirjam joined our highly recommended life sciences team, she worked as a lawyer for another international law firm in Munich in the areas Life Sciences, IP, and Corporate and Commercial.
Representative experience
Drafting and creating compliance policies for national and international companies in the healthcare sector.
Advising international companies on the contractual relationship with healthcare professionals and clinical institutions regarding the conduct of market research projects.
Advising an international pharmaceutical company on regulatory aspects regarding the distribution of their products.
Advising various companies on the classification of medicinal apps as medical device.
Advising an international pharmaceutical company on the reimbursement of medicinal services for the benefit of patients and health insurance companies.
Advising a global pharmaceutical company on customer redress claims.
COVID 19 - Advising companies from various industry sectors on the manufacture and supply of masks, including advice on different regulatory requirements.
Advising an international pharmaceutical company on granting discounts on pharmaceutical products.
Advising national and international companies on the set-up of new and already existing patient-support programs, including their launch.
Review of promotional and non-promotional material of various pharmaceutical and medical device companies.
Advising pharmaceutical and medical device companies on ad boards, symposia, congresses, consultant services, internal training sessions, donations etc.
Advising pharmaceutical companies on pre‑approval activities and supporting national and international firms during product launches.
Credentials
Education
- Second State Exam in Law, Higher Regional Court of Hamburg, 2016
- Dr. iur., University of Hamburg, 2015
- First State Exam in Law, Bucerius Law School, 2011
- LL.B., Bucerius Law School, 2010
- Study Abroad, Dalhousie University Law School, Halifax, Nova Scotia, Canada, 2008